Ben Bridgewater is chief executive of Health Innovation Manchester, an academic health science system that brings together health, academia and industry. The mission is to accelerate innovation into practice at pace and scale, so to transform the lives of Greater Manchester’s 2.8 million citizens.
He is a leading expert on health informatics, national clinical audit, clinical governance, healthcare transparency, patient experience measurement and digital transformation in healthcare, publishing numerous high profile academic outputs and delivering innovative IT tools for disseminating clinical outcomes to professionals and the public.
Prior to joining Health Innovation Manchester, Ben worked for global technology company DXC Technology as the director of the Healthcare and Life Sciences global build advisory team. Until January 2016, he was a cardiac surgeon at the University Hospital of South Manchester for nearly 18 years. Ben also provided clinical leadership for the UK national cardiac audit programme, as well as leading analyses that provides UK hospital and cardiac surgery mortality rates to the public. The programme is world-leading and associated with a 50% reduction in risk-adjusted mortality over 10 years.
Sir Robert Francis QC is a barrister practising at Serjeants’ Inn Chambers, a recorder and sits as a deputy High Court judge. He specialises in medical law. He acts for claimants and defendants in clinical negligence claims. He has extensive experience in healthcare professional disciplinary cases, and making decisions for those unable to do so themselves. He has chaired a number of inquiries including the Mid-Staffordshire NHS Foundation Trust public inquiry and the ‘Freedom to speak up’ review. He is a chairman of Healthwatch England, and a non-executive director of the Care Quality Commission. He is a trustee of the Point of Care Foundation, president of the Patients Association and patron of the Florence Nightingale Foundation. He is an affiliate of the Doubleday Centre for Patient Experience, Manchester University. He has been awarded honorary fellowships of the Royal College of Anaesthetists, the Royal College of Surgeons and the Royal College of Pathologists. He was knighted for services to healthcare and patients.
Professor Andrew Goddard is the president of the RCP, and a consultant physician and gastroenterologist at Royal Derby Hospital.
After gaining an MD from Cambridge University, Professor Goddard trained in Nottingham and was appointed as a consultant physician and gastroenterologist in Derby in 2001. His main clinical and research interests are bowel cancer screening, H. pylori, iron deficiency anaemia and inflammatory bowel disease. He is chair of the British Society of Gastroenterology gastroduodenal section.
He was director of the RCP’s Medical Workforce Unit for 5 years until being appointed RCP registrar in 2014. In this role, he oversaw professional and clinical affairs, both in the UK and internationally. His main policy areas were workforce, healthcare funding, the future of general medicine, the medical registrar and ‘keeping medicine brilliant’. In 2018 he was elected the 121st RCP president, the youngest for 400 years and first from the East Midlands.
Matt Hancock MP was appointed Secretary of State for Health and Social Care on 9 July 2018.
He was Secretary of State for Digital, Culture, Media and Sport from 8 January 2018 to 9 July 2018. He was previously Minister of State for Digital from July 2016 to January 2018.
Matt Hancock is the MP for West Suffolk, having been elected in the 2010 general election. From 2010 Matt served as a backbencher on the Public Accounts Committee and the Standards & Privileges Committee. Matt entered government in September 2012 and has served in a number of Ministerial Roles, including for skills and business, and as Paymaster General. He oversaw the expansion of apprenticeships, and championed the digital transformation of government.
From July 2016 he served at DCMS as Minister of State for Digital and was responsible for broadband, broadcasting, creative industries, cyber and the tech industry.
Before entering politics, Matt worked for his family business, as an economist at the Bank of England, and as Chief of Staff to the Shadow Chancellor of the Exchequer. He holds degrees from Oxford and Cambridge Universities.
Matt is married to Martha and has three young children. He is the first MP in modern times to win a horse race, having raced to victory at the Newmarket July Course in August 2012. He is an avid cricketer and plays for the Lords & Commons Cricket team. Matthew once played the most northerly game of cricket on record, and succumbed to frostbite en route to the Pole. He retains all his fingers
Dido became Chair of NHS Improvement on 30 October 2017.
She is a non-executive director on The Court of The Bank of England and Chair of the Bank’s Remuneration Committee. She was Chief Executive of TalkTalk Telecom Group PLC from 2010 to May 2017. Prior to TalkTalk, Dido was Sainsbury’s convenience director, having been appointed to Sainsbury’s operating board in March 2008. Dido joined Sainsbury’s from Tesco PLC where she held a variety of senior roles both in the UK and international businesses.
Prior to this, she worked at Kingfisher plc and Thomas Cook Limited where she gained considerable retail experience. She has also served on the boards of The British Land Company PLC and Cheltenham Racecourse. She is a trustee of Doteveryone and a member of the UK National Holocaust Foundation Board.
In August 2014 Dido was offered a Peerage and sits in the House of Lords as a Conservative Peer. She was appointed to the Economic Affairs Committee of the Lords in July 2017. Dido is married to politician John Penrose, has two children and in what spare time she has left is a jockey and racehorse owner.
Professor Beverley Hunt is professor of thrombosis and haemostasis at King’s College London; a consultant in the departments of haematology and pathology at Guy’s & St Thomas NHS Foundation Trust; and clinical lead in haematological sciences at Viapath
She has a large clinical practice, specialising in thrombosis and haemostasis, especially in inherited and acquired thrombophilias, obstetric haematology and acquired bleeding disorders. She is a national and international expert in thrombosis and acquired bleeding disorders. In England, she works frequently with the National Institute of Clinical Excellence (NICE), and is on their expert panel and is involved in rewriting the NICE thromboprophylaxis guidelines.
Her work is recognised internationally and she is honorary president of VTE Ireland, and the ambassador for the antipidean organisation HOW (Haematologists in Obstetric & Womens health). She sits on the editorial board of the British Journal for Haematology, Journal of Thrombosis and Haemostasis, Lupus, and Seminars in Thrombosis & Hemostasis. She is a chair in the International Society of Thrombosis and Heamostasis (ISTH) perioperative haemostasis group.
She runs a research group with over 300 peer-reviewed publications to her name, and won the BMJ Research paper of the year in 2011 with the CRASH-2 team.
She is founder and now medical director of the thrombosis charity ‘Lifeblood: the thrombosis charity’, now Thrombosis UK which was Health Charity of the Year 2010 for its campaigning to improve patient care in the UK. She is part of a global team organising the global ‘World Thrombosis Day’.
Dr Orod Osanlou is an ST7 in Clinical Pharmacology and Therapeutics, and General Internal Medicine. He works at the Royal Liverpool University Hospital, where he is also a sub-investigator for phase I clinical trials.
He was the first person to complete the RCP Chief Registrar programme in leadership and management and has completed the Elizabeth Garrett Anderson MSc in Medical Leadership ran by the NHS Leadership Academy.
Orod has a keen interest in medical education, has a Postgraduate Certificate in Medical Education, is a Fellow of the Higher Education Academy and is an honorary lecturer at the University of Liverpool.
He is a part time PhD student in pharmacology and health economics and has publications in the areas of pharmacology, internal medicine and medical leadership.
Orod has guest edited an edition of the Future Healthcare Journal, and set up the first RCP trainees conference in 2018, both of which had a focus on medical leadership, training and holistic support for junior doctors.
He has represented junior doctors on a local, regional and national level has previously sat on RCP London Council, helping to improve the training and working lives of junior doctors.
Stephen Powis is the national medical director of NHS England and professor of renal medicine at University College London.
Previously he was medical director (and latterly group chief medical officer) of the Royal Free London NHS Foundation Trust from 2006 to 2018. Professor Powis was also a member of the governing body of Merton Clinical Commissioning Group for 5 years and a director of Healthcare Services Laboratories LLP. He is a past chairman of the Association of UK Universities (AUKUH) Medical Directors Group, and has been a member of numerous national committees and working groups, including the Department of Health Strategic Education Funding Expert Group. He is a past non-executive director of the North Middlesex University Hospital NHS Trust, including a period of 8 months as acting chairman.
He is a past chairman of the Joint Royal Colleges of Physicians Training Board (JRCPTB) specialty advisory committee (SAC) for renal medicine and a former board member of Medical Education England. He was director of Postgraduate Medical and Dental Education for UCLPartners from 2010–13. He is a past treasurer and trustee of the British Transplantation Society and a former member of the UK transplant kidney and pancreas advisory group. He has also served as a member of the Renal Association Executive Committee. He was editor of the journal Nephron Clinical Practice from 2003 to 2008. In 2017 he became the inaugural editor-in-chief of the journal BMJ Leader. He has been a trustee of several charities, including the Royal Free Charity and the Healthcare Management Trust.
Andrew Thompson is co-founder, president and chief executive officer of Proteus Digital Health. His vision for digital medicine is focused on expanding global access to care, dramatically increasing the value delivered by drugs and creating a more sustainable model for innovation that leverages the mobile device in everyone’s pocket.
He is also a co-founder and board member of Summit Schools, a leading Charter School organisation with an acclaimed track record and unique digital platform, featured in the Davis Guggenheim movie ‘Waiting for Superman‘.
Thompson is active in digital humanities innovation as a member of the Stanford University Libraries and Academic Information Resources Council and with Cambridge University. He is a co-founder of Parker Library Online – a leading destination for digital medieval studies.
He holds master’s degrees in engineering (Cambridge), education (Stanford) and business (Stanford GSB), and has a successful 25-year track record starting and building technology-based healthcare companies in Silicon Valley.
Karen trained as an academic rheumatologist with a special interest in occupation and musculoskeletal pain in Southampton. Karen is based at the Medical Research Council (MRC) Lifecourse Epidemiology Unit in Southampton where she is professor and honorary consultant in occupational rheumatology and director of the Arthritis Research UK/MRC Centre for Musculoskeletal Health and Work. She leads the multidisciplinary centre and coordinates a programme of work to find cost-effective ways to reduce the burden of disability for work caused by musculoskeletal disorders. She was awarded an honorary fellowship of the Faculty of Occupational Medicine in 2013.
David Adams is Pro-Vice-Chancellor, Head of College of Medical and Dental Sciences and the Dean of Medicine. The College has over 1,500 staff and brings together healthcare-related research and education including medicine, dentistry, nursing, physiotherapy and biomedical sciences.
David is also Director of Birmingham Health Partners, a strategic alliance between the University, University Hospitals Birmingham NHS Foundation Trust and Birmingham Women’s and Children’s NHS Foundation Trust, bringing together clinical, scientific and academic excellence across an integrated medical and life sciences campus, and Director of the NIHR Birmingham Biomedical Research Centre.
David’s clinical interests are transplant hepatology and autoimmune liver disease. Laboratory research interests are focused on mechanisms of immune-mediated liver disease. After initial training in hepatology in Birmingham he continued his immunology training with Dr Stephen Shaw at the Experimental Immunology Branch of the National Cancer Institute, Bethesda, USA before being appointed to the Chair of hepatology in Birmingham in 1997. He is currently an associate editor of the Journal of hepatology. He served on the scientific committee and governing board of the European Association for Study of the Liver between 2004-2007 and its Ethics committee 2010-2015. David was a councillor for the European Society for Organ Transplantation between 2004-2008. He was made a Fellow of the Academy of Medical Sciences in 2000.
David has a long-standing interest in understanding how leukocyte-endothelial interactions regulate the recruitment of effector cells in chronic liver disease and his group have defined molecular mechanisms used by hepatic endothelium to control the entry of leukocytes from the blood. They have recently begun to use this information to develop new therapy for liver disease by targeting pathways involved in the recruitment of damaging effector cells or by promoting the recruitment of therapeutic cells including dendritic cells, stem cells and regulatory T cells that may be used to manipulate immune responses in patients in vivo.
Eric is Professor of Gene Therapy and Respiratory Medicine at Imperial College, London and an Honorary Consultant Physician at the Royal Brompton Hospital. Over the last 15 years he has coordinated the UK Cystic Fibrosis Gene Therapy Consortium, which brings together all the key centres in the UK (Edinburgh and Oxford Universities and Imperial College, London) in a programme to deliver gene therapy for these patients. Based on the cystic fibrosis programme, the Consortium is now also applying the underpinning gene delivery technology to a number of other diseases. He is the Lead for Cluster B of the NIHR CRN, coordinating portfolio studies in respiratory, ENT, gastroenterology, hepatology and infection.
Dr Anderson is a consultant neurologist and the clinical lead for the refractory headache service at Addenbrooke’s Hospital, Cambridge. She qualified in medicine from the University of Edinburgh and trained in clinical neurology in Southampton, Cambridge, Norwich and London. Dr Anderson’s specialist interests focus on the management of cranio-cervical pain and movement disorders with specific interest in the primary refractory headache disorders (chronic migraine, vestibular migraine and the trigeminal autonomic cephalagias).
She retains an honorary position in the Headache Group in the National Hospital for Neurology and Neurosurgery, but works principally between Addenbrooke’s and Princess Alexandra Hospital. She sits on the advisory group for headache and pain for the Association of British Neurologists.
John Atherton’s medical education was at Cambridge then Oxford University. After postgraduate training in medicine and gastroenterology, he trained in gastroenterology research with Professors Chris Hawkey and Robin Spiller in the UK, and in infectious disease research with Professors Martin Blaser and Timothy Cover in Vanderbilt University, USA. He settled in the University of Nottingham in 1995 and became a full professor in 2001. In this role John continues to practice clinical gastroenterology as an NHS consultant, through patient clinics and endoscopy lists, specialising in upper GI diseases. He teaches medical students and specialised masters students. His main research interests are in the virulence of the stomach bacterium Helicobacter pylori, in the pathogenesis of peptic ulceration and gastric adenocarcinoma, and in the role of H. pylori in modulating other diseases. He supervises both laboratory and clinical research and particularly enjoys supervising PhD students. He has held both Medical Research Council (MRC) clinician scientist and senior fellowships and was awarded the Sir Francis Avery Jones Research Medal by the British Society of Gastroenterology.
John was founding director of the National Institute for Health Research (NIHR) Biomedical Research Unit in the Nottingham Digestive Diseases Centre. From 2009 to 2013 he was head of the School of Clinical Sciences in the University of Nottingham then from 2013 to 2015 dean of the School of Medicine. Since 2015 he has been pro-vice chancellor and dean of the Faculty of Medicine and Health Sciences.
Outside Nottingham, John is the secretary-general of United European Gastroenterology, the body representing gastroenterologists and others interested in digestive diseases in Europe, and also serves on the UK Medical Schools Council Executive as treasurer.
Professor Simon Barton is clinical co-chair of the Blood and Infection programme and Care Board at NHS England. He is a consultant physician and divisional medical director at Chelsea and Westminster Healthcare NHS Foundation Trust, where he has worked since 1989 .
He is a past president of the British Association for Sexual Health and HIV, and the UK specialty representative to the European Union of Medical Specialists (UEMS). His research interest is in therapy for herpes simplex virus (HSV) infection and interactions of sexually-transmitted infections (STIs) with HIV infection.
Hussain is a Respiratory and General Internal Medical Registrar from the Kent, Surrey, and Sussex Region, and is currently working as an Education Fellow at the Royal College of Physicians.
He has an interest in interprofessional learning in the workplace, and the recruitment and retention of NHS staff, and feels very lucky to be involved in RCP project work with regards to both (Never too busy to learn and flexible portfolio training).
Dr Rachel Batterham is professor of obesity, diabetes and endocrinology at University College London (UCL). She holds a prestigious National Institute of Health (NIHR) Research Professorship (2016–2021). She established and leads the University College London Hospital (UCLH) Bariatric Centre for Weight Management and Metabolic Surgery. She leads the UCL Centre for Obesity Research within the Department of Medicine and is the director for the UCLH/UCL NIHR Biomedical Research Centre obesity research theme.
Professor Batterham’s laboratory research is focused on increasing our understanding of body weight regulation and developing new therapies for the treatment of patients with obesity and type 2 diabetes. She has received several international awards including the Royal Society of Medicine Steven’s Lecture (2018), Andre Mayer award from the World Obesity Federation (2016), the Diabetes UK Rank Fund Nutrition Prize (2015), the Lilly Scientific Achievement Award from The Obesity Society (2014), and the Linacre Medical from the Royal College of Physicians (2010).
Professor Batterham has made significant clinical contributions to defining the management of obese patients through her membership of the NICE Obesity Guideline Development Group and Royal College of Physicians Advisory Group on Health and Weight. Professor Batterham is currently a NICE clinical expert (2016–2021), scientific chair for the International Federation for Surgery for Obesity and Metabolic Diseases (IFSO) European Chapter (since 2015), a trustee for the Association for the Study of Obesity (since 2016), and council member for the British Obesity and Metabolic Surgery Society (since 2016).
Dr Amanda Begley is Director of Innovation and Implementation at UCLPartners. Her focus is to build partnerships and expertise to deliver innovation at scale and pace for patient and population benefit.
She is co-founder and National Director for the NHS Innovation Accelerator (NIA), which is delivered as a partnership between NHS England and the country’s 15 Academic Health Science Networks, hosted at UCLPartners.
Following her PhD, Amanda joined the NHS as an Assistant and Trainee Clinical Psychologist. She has worked as a commissioner and senior manager across primary, community and secondary care, and as Head of Innovation at London’s Strategic Health Authority. While at UCLPartners, Amanda completed a Fellowship at GSK and was recently named in the NHS 70 Women Leader Awards, presented by the NHS London Leadership Academy.
Dr Booton graduated from the University of Leeds and completed higher specialist training in the north-west of England and a thoracic oncology fellowship at The Christie Hospital & Paterson Institute for Cancer Research with Professor Nick Thatcher, receiving his PhD in 2006. He was appointed in 2008 as consultant respiratory and thoracic oncology physician, and is currently lead lung cancer clinician and clinical director for thoracic oncology at the Manchester Thoracic Oncology Centre, Wythenshawe Hospital. He was inaugural early detection theme lead for Cancer Research UK Lung Cancer Centre of Excellence. He is a member of the faculty of the British Thoracic Oncology Group, UK and Ireland representative for the International Association for Study of Lung Cancer, and member of the NHS Expert Advisory Group for targeted lung cancer screening.
Director Sean Cross is involved in the following professional roles; Managing Director, Maudsley Learning, Maudlsey Hospital Consultant Liaison Psychiatrist, Maudsley and King’s College Hospitals, Clinical Director, Mind and Body Programme, King’s Health Partners AHSC
Director, Maudsley Simulation, Maudsley Hospital.
Director Cross has a degree in BSc(Hons) Bachelors in Molecular Biology, MBChB Bachelors in Medicine and Surgery, a MSt Masters in International Relations and a
MD(Res) Doctorate in Cultural Psychiatry., he is also a member of
the MRCPsych Royal College of Psychiatrists.
Director Sean Cross completed his undergraduate medical degree at the University of Edinburgh (2000),has a masters degree, from the University of Cambridge (2007) and subsequently and a
doctoral research degree at the Institute of Psychiatry, Psychology and Neuroscience,
King’s College London (2015). He undertook his post-graduate clinical training in
Edinburgh, Sydney and London. Director Sean Cross is a member of the Royal College of Psychiatrists and he is on the GMC Specialist Register for General Adult Psychiatry with subspecialist accreditations in Liaison and Rehabilitation Psychiatry.
He was awarded national trainer of the year in 2012 by the RCPsych, and run projects on
service development around mental and physical healthcare and on medical.
Charlie Davie is managing director of UCLPartners and is a consultant neurologist at the Royal Free London NHS Foundation Trust.
Charlie has played an integral leadership role in UCLPartners since 2009, when he was the stroke lead during the reconfiguration of services and establishment of hyper acute stroke units in London. Charlie subsequently became programme director for neurosciences, before taking on the role of managing director of the Academic Health Science Network (AHSN) in 2014. During this time, Charlie has taken the AHSN from strength-to-strength and provided strategic direction for high-profile initiatives including: NHS Test Beds, Accelerated Access Review, NHS Innovation Accelerator and DigitalHealth.London.
Charlie has held a number of national advisory roles, most recently as a member of the Accelerated Access Collaborative Steering Group. Charlie has been an editor of the European Journal of Neurology for over 12 years and has published extensively in several areas of clinical neuroscience. He has previously been a substantive senior lecturer in neuroscience at UCL (1999–2004), and guest lectured at Harvard Business School on value-based healthcare delivery with Michael Porter.
Charlie has over 30 years’ continuous clinical service in the NHS and is a fellow of the Royal College of Physicians.
Dr Tina Dutt is a consultant haematologist and honorary clinical lecturer at the Royal Liverpool University Hospital.
During her medical training she completed a BSc (Hons) in pharmacology and later obtained a PhD supported by multiple awards including a prestigious Medical Research Council (MRC) clinical fellowship, British Heart Foundation grant and Bayer clinical scholarship.
Dr Dutt has created a national profile in pioneering the acute management of thrombotic microangiopathies (TMAs). After presenting a compelling vision for change locally she has successfully led major service innovation culminating in the first regional centre in the north of England for patients with the life-threatening condition thrombotic thrombocytopaenic purpura (TTP). The service delivers urgent, specialist, patient-centred care where the excellent quality of care is evidenced by a patient survival close to 100% since setup in July 2013.
Dr Dutt is also clinical trials lead at her centre and has received national awards from the RCP, British Society for Heamatology (BSH) and National Institute for Health Research (NIHR) recognising her commitment to providing clinical research opportunities in particular for patients with rare and chronic disease.
Currently, Dr Dutt is dedicated to ensuring that TMA patients have access to high-quality specialist care and prompt life-saving treatment. This includes establishing a robust national framework for managing this patient group together with NHS England specialist commissioners based on improved outcomes and patient experience.
Dr Ian Forrest is a Consultant Respiratory Physician at the Royal Victoria Infirmary, Newcastle upon Tyne. He established the Newcastle Interstitial Lung Disease service in 2006 which has since grown into one of the largest specialised services in the UK. As clinical ILD lead, he has an active interest in clinical research but also remains committed to both general respiratory medicine and GIM. He is the Training Programme Director for Respiratory Medicine in the Northern Region. He has previously served as an Associate Clinical Sub-Dean, Newcastle University and chair of the BTS Education and Training committee.
Professor Della Freeth leads the Education directorate at the RCP, which supports the professional development of doctors and other healthcare professionals in the UK and around the world.
This focuses on working in partnership with others, providing excellent education courses and learning resources of many types; providing consultancy and bespoke developments; supporting high-quality assessment; and responding to contemporary needs such as credentialing, learning for flexible and portfolio careers, learning in busy workplaces, interprofessional collaboration, quality improvement, developing clinician researchers and supporting transitions to leadership roles.
Prior to joining the RCP in 2017, Della’s academic career spanned four universities in research and university leadership roles, most recently as pro-director of learning and teaching, and professor of professional education at the London School of Hygiene & Tropical Medicine. Her academic work, in partnership with healthcare professionals and teams, focuses on learning in workplaces, interprofessional collaboration, patient safety and learning through simulated professional practice.
Working with colleagues at the School of Medicine & Dentistry, Queen Mary University of London, Della continues to supervise research students from a range of healthcare professions.
Dr Garthwaite graduated from the University of Leeds Medical School in 1997. After completing nephrology and general medical training in the Yorkshire Region she was appointed consultant nephrologist in Leeds in 2008, where she leads the haemodialysis service, and junior doctor training and supervision.
Her interests include empowering patients to share in decision making and to take responsibility for their health; teaching patients on haemodialysis to participate in their own treatment through the initiative of ‘Shared haemodialysis care’.
Having completed a higher degree in medical education she has responsibility for trainee supervision in the trust and is the training programme director for renal in Yorkshire and the Humber. She has a passion for supporting trainees, through teaching, training and coaching and enjoys teaching both undergraduate and postgraduates.
Outside work she is a keen musician; a reluctant runner; but most importantly, and enjoyably, a mum of four children.
Linda Gask has now retired from clinical practice after working for more than 30 years as a psychiatrist in the National Health Service and in recent years with a social enterprise providing primary care based mental health services in Salford. She is also an academic, affiliated to the Centre for Primary Care at the University of Manchester where she is now Emerita Professor of Primary Care Psychiatry. Her research and teaching interests are the management of depression, anxiety and other mental health problems in primary care for which she has an international reputation. In 2000-2001 she spent a year in the USA as a Harkness Fellow in healthcare policy and practice. She co-founded the STORM suicide prevention initiative, which has now been disseminated internationally. Linda has served on the board of the World Psychiatric Association, chaired the Section of Education and has worked as an advisor to the World Health Organization.
Her memoir: The Other Side of Silence: A Psychiatrist’s Memoir of Depression was published in 2015.
John Hurst is professor of respiratory medicine at University College London. He has a clinical and research interest in exacerbations of COPD. He qualified from the University of Edinburgh Medical School in 1997 and has worked at UCL since 2007. His clinical work is based at Royal Free London NHS Foundation Trust, and in the Barnet and Camden community respiratory services. He is COPD audit lead for the Royal College of Physicians National Asthma and COPD Audit Programme (NACAP). He has national and international roles with the American and British Thoracic, and European Respiratory Societies, and from January 2019 will be editor-in-Chief of the European Respiratory Monograph.
Founder and Medical Director of medDigital and medCrowd.
Felix is a doctor and entrepreneur developing digital technology for health and care. He trained as an Anaesthetist leaving clinical practice to found medDigital.
After joining DigitalHealth.London’s Accelerator, he launched medCrowd in 2017. medCrowd is the instant messenger for health and care that keeps everyone in touch while protecting confidential information to the required standards.
He is particularly enjoying being part of how digital is transforming health and care for the better.
Mariam Jamal-Hanjani is a senior clinical lecturer and consultant medical oncologist at the UCL Cancer Institute in London. She completed her undergraduate degrees in physics and medicine at UCL followed by her clinical training in London. In 2012 she was awarded a Cancer Research UK Clinical Research fellowship for her PhD studies in chromosomal instability and intratumour heterogeneity. In 2016 she was awarded an National Institute for Health Research (NIHR) clinical lectureship to continue her research in lung translational oncology. She has been involved in establishing, and is the principle investigator for, the multi-centre Cancer Research UK TRACERx (TRAcking cancer evolution through therapy [Rx]) and post-mortem PEACE (post-humous evaluation of advanced cancer environment) studies. Her research interests include tumour evolution, determining the impact of intratumour heterogeneity on therapeutic response and clinical outcome, and utilising the tumour neoantigen repertoire to develop adoptive T-cell therapies.
Dr Jones is a consultant neurologist at the Manchester Centre for Clinical Neurosciences, Salford Royal Foundation Trust, UK. He is also an honorary senior lecturer at the University of Manchester.
His clinical interests are general and acute neurology with sub-specialisation in cognitive neurology; he runs a tertiary clinic at the cerebral function unit for early onset and atypical dementia taking referrals from throughout the north-west of the UK and beyond.
His research interests are in the clinical, genetic and pathological classification of focal dementia syndromes. He has also been principle investigator for a number of clinical trials in dementia and brain infection.
His teaching interests lie in both undergraduate and postgraduate education. He is academic lead for year 4 of the MBChB programme in Manchester and has been co-directing the Manchester MRCP course since 2006.
Dr Mike Jones, head of training and development, Joint Royal Colleges of Physicians Training Board
Dr Mike Jones was appointed as the head of training and development in November 2018 and brings a wealth of knowledge and experience to the role, having previously been the chair of the JRCPTB Acute (Internal) Medicine Specialty Advisory Committee and has been involved in the development of the new Internal Medicine Stage 1 curriculum. He is also the former President of the Society for Acute Internal Medicine and the Dean and Vice President of the Royal College of Physicians of Edinburgh. Most recently he has been the Director of Training & Standards for the Edinburgh College.
Dr Jones is currently a Consultant Physician and Clinical Director at the University Hospital of North Durham.
Dr Binita Kane is a consultant respiratory physician at Manchester University Foundation Trust (MFT) and has an interest in airways disease, quality improvement (QI) and leadership. She is currently the lead for respiratory integrated care at MFT, the Greater Manchester COPD health innovation programme and the North West Severe Asthma Network. She is a member of the RCP QI faculty and the National Asthma and COPD Audit Programme (NACAP) board.
Dr Lee qualified from Edinburgh University in 1991, and completed her subsequent MD thesis in 2000, during her specialist registrar training on the west of Scotland programme. She gained her substantive consultant post within Northumbria in 2002 and set up the Northumbria cardiac magnetic resonance imaging (MRI) service in 2003, progressively developing the modality over 15 years. She gained level 3 accreditation in cardiovascular magnetic resonance (CMR) from the EuroCMR in 2013, and has British Society of Cardiovascular Imaging (BSCI) accreditation in cardiac computed tomography (CT). Dr Lee was fundamental in the creation in 2013 of the regional sub-specialty interest forum called the North East CMR Imaging group (NECMR). The NECMR holds regular open access meetings for education and governance in CMR, and runs very successful registrar and consultant courses in CMR. Dr Lee also holds honorary clinical senior lecturer status within the Newcastle University Medical School.
Gillian Leng is the Deputy Chief Executive at NICE and a visiting professor at King’s College London. Gillian trained in medicine at Leeds, and studied for an M.D. at Edinburgh University. She was involved in the Cochrane Collaboration as it became established, and still contributes as an editor. She worked as a consultant in public health medicine before moving to NICE in 2001. At NICE, Gillian led the set up of several major programmes, including for clinical guidelines programme, implementation, social care, quality standards and indicators and the NHS Evidence portal. Gillian chairs the national Shared Decision Making Collaborative and sits on several national boards. She is actively involved in research into quality improvement, and is a trustee at the Royal Society of Medicine, and the Guidelines International Network.
Professor Lip, MD, is Price-Evans chair of cardiovascular medicine at the University of Liverpool, UK – and director of the Liverpool Centre for Cardiovascular Science at the University of Liverpool and Liverpool Heart & Chest Hospital. He is also distinguished professor at Aalborg University, Denmark; and adjunct professor, Yonsei University, Seoul, Korea.
Half of his time is spent as a clinical cardiologist, including outpatient clinics (leading large atrial fibrillation and hypertension specialist services) and acute cardiology.
Professor Lip has had a major interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores – for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research, and are now incorporated into international guidelines. In 2014, Professor Lip was ranked by Expertscape as one of the world’s leading experts in the understanding and treatment of AF.
Professor Lip was on the writing committee for various international guidelines, including the American College of Chest Physicians (ACCP) Antithrombotic therapy guidelines for atrial fibrillation, as well as various guidelines and/or position statements from the European Society of Cardiology (ESC) or European Heart Rhythm Association (EHRA). Specifically, he was also on the writing committees of the 2010 ESC Guidelines on Atrial fibrillation, the 2012 ESC Focused update guidelines on atrial fibrillation, the 2012 ESC Guidelines on heart failure, and the 2014 NICE guidelines on AF. He was deputy editor (‘content expert’) for the 9thACCP guidelines on antithrombotic therapy for AF (2012), and chair of the new 2018 ACCP guidelines on antithrombotic therapy for AF.
Professor Lip has acted as senior section editor for major international textbooks and at senior editorial level for major international journals, including Thrombosis & Haemostasis (editor-in-chief, clinical studies); Europace (associate editor); and Circulation (guest editor).
Dr Kate Lovett studied Medicine at the Universities of St. Andrews and Manchester. Having been awarded a Distinction in Psychiatry at finals, Kate trained as a Psychiatrist in the Northwest obtaining the MRCPsych in 1995. She completed an MSc in Clinical Psychiatry in 1997 researching the role of ovarian steroids in postnatal depression. Kate trained both full time and flexibly completing specialist training in 2001. She has worked for Devon Partnership Trust as a Consultant Psychiatrist in General Adult Psychiatry since 2001 as an inpatient and crisis consultant. She was an Associate Medical Director between 2008 and 2010 and has been in her current role as a community psychiatrist for the past 5 years.
Kate has a longstanding interest in training and education. She has been undergraduate Psychiatry lead for Peninsula Medical School and Training Programme Director for Adult Psychiatry. Kate completed a Postgraduate Certificate of Clinical Education with Distinction in 2008. She served on the Education, Training and Standards Committee at the Royal College of Psychiatrists between 2010 and 2014 and on the South West Division between 2010 and 2016. Kate was appointed as CASC (Clinical Assessment of Skills and Competencies) examiner in 2008 and became a lead examiner in 2014. She was Head of School of Psychiatry for the Peninsula Deanery for four and a half years until 2016 when she gave up this role having been elected Dean of the Royal College of Psychiatrists. In that role she has lead work on recruitment and retention in the mental health workforce and been a driving force behind the #ChoosePsychiatry campaign. Her drive to develop systems that support compassionate care and recovery fuels her educational leadership and is underpinned by values of equity and fairness”
Dr Deb Lowe is a consultant stroke physician and geriatrician at Wirral University Teaching Hospital NHS Foundation Trust and is the national clinical lead for stroke with the NHS Improvement ‘Getting it right first time’ (GIRFT) programme.
She graduated from Liverpool Medical School in 1997 and did her postgraduate medical training within the Merseyside and Cheshire region. She completed a research fellows post at Aintree University Teaching Hospital and has an interest in patient empowerment and education.
Since 2008 she has been a clinical service lead for stroke, elderly care and rehabilitation, and more recently clinical director for the Division of Medicine.
Deb has been clinical lead for stroke within the Strategic Clinical Networks and Senate since 2014, and has led peer support service reviews across the region over the last few years and has comprehensive knowledge of stroke services across country. She was appointed in November 2017 as national stroke lead with GIRFT and within this role she is keen to promote a culture of effective clinical engagement and leadership, accurate performance monitoring and the use of high quality data to drive sustainable quality improvement.
She delivers education both within primary and secondary care to improve knowledge and understanding of stroke, and most importantly the management of atrial fibrillation and other modifiable risk factors.
Professor Sheona Macleod is the deputy medical director for Medical Education Reform; postgraduate dean in the east Midlands; chair of Health Education England’s (HEE) deans; and chair of the UK Conference of Postgraduate Medical Deans (COPMED).
She is an honorary professor of the University of Nottingham and the University of Leicester, and the recruitment adviser in HEE.
Sheona graduated, and trained in Glasgow, before moving to Derbyshire, where she was a GP for 26 years. She has also worked as the occupational health adviser to a number of regional industries, as clinical assistant in the local community hospital, and as a medical officer for Her Majesty’s Prison service.
She has been involved in healthcare education since moving to Derbyshire, and was appointed as GP Dean in 2009, and as Postgraduate Dean in September 2012. She was also the regional Director of Education and Quality from 2013 to 2014.
Sheona chairs a number of national working groups and committees, including the HEE working group on Enhancing Junior Doctors Working Lives.
Dr Alastair Miller, deputy medical director, Joint Royal Colleges of Physicians Training Board
Dr Alastair Miller was a Consultant Physician in the Tropical & Infectious Disease Unit at the Royal Liverpool University Hospital and an Honorary Fellow at the Liverpool School of Tropical Medicine from 2005 until May 2014. Dr Miller has a particular interest in Medical Education. He chaired the Specialist Advisory Committee on Infectious Disease and Tropical Medicine for 6 years. He is on the Faculty of the Doctors as Educators programme and external examiner for the Leadership and Management programme at Edge Hill University. He has been an MRCP clinical examiner for over 10 years and has also been an examiner for the theory paper and for the DTM&H. He has been Deputy Medical Director of JRCPTB since August 2013.
Rahul is a Specialist Registrar in Cardiology at Guy’s and St Thomas’ Hospital. He has followed the Integrated Academic Training Pathway throughout his clinical career and is passionate about research. Rahul was appointed to an Academic Foundation program in Cardiology at King’s College Hospital, London in 2011 followed by a NIHR Academic Clinical Fellowship in Cardiovascular Medicine in 2013 at Guy’s and St Thomas’ Hospital. Since 2016, he has been working towards a PhD in cardiac electrophysiology which has been funded by the Wellcome Trust and a Fellowship in Translational Medicine from the NIHR Biomedical Research Centre. His research incorporates an inter-disciplinary approach combining cardiac imaging, computational modelling and cardiac electrophysiology and involves close collaborations with industry. His work has led to publications in leading specialty journals: Circulation: Arrhythmia and Electrophysiology, Europace, Journal of Cardiovascular Electrophysiology and Journal of Magnetic Resonance Imaging. He is an Associate Editor of Clinical Medicine and is a reviewer for the Journal of Cardiovascular Magnetic Resonance and the Journal of Interventional Cardiac Electrophysiology.
Catherine Nelson-Piercy is a consultant obstetric physician at Guy’s and St Thomas’ Hospitals Trust and Queen Charlotte’s and Chelsea Hospital in London. In 2010 she was awarded the title of professor of obstetric medicine at King’s College London. Her undergraduate studies were at King’s College, Cambridge University and St Bartholomew’s Hospital. She trained as a physician, and was taught obstetric medicine by Professor Michael de Swiet.
Professor Nelson-Piercy is past president of the International Society of Obstetric Medicine (ISOM). She is founding co-editor in chief of the journal ‘Obstetric Medicine: the medicine of pregnancy.’
Professor Nelson-Piercy has been involved in the development of several evidence-based national guidelines notably for Contraception in women with heart disease‘, British Thoracic Society (BTS) / Scottish International Guidelines Network (SIGN) Asthma in pregnancy and Royal College of Obstetricians and Gynaecologists (RCOG’s) green top guidelines on Reducing the risk of thromboembolism during pregnancy, birth and the puerperium and Management of nausea vomiting of pregnancy and hyperemesis gravidarum. She has over 200 publications and has edited five books and written the successful Handbook of Obstetric Medicine, now in its fifth edition. She is also one of the central physician assessors for the UK Confidential maternal deaths enquiry.
Dr David Nicholl is clinical lead for neurology at Sandwell & West Birmingham NHS Trust and RCP tutor at University Hospital Birmingham. He is honorary secretary to the Association of British Neurologists and was on the Board of Trustees of the RCP until December 2018. He is passionate about medical education and clinical neurology: he has organised the ‘Birmingham movement disorders’ course since 2004 and set up the ‘Brief neuro’ exam on YouTube to help improve the quality of neurological assessment (with over half a million views).
Professor Chuka Nwokolo took up the post of RCP treasurer on 1 November 2016, after 6 months as deputy treasurer. As treasurer, he has oversight of finance and resource issues, and leads on the RCP strategic theme of building on our heritage and investing in our future.
Chuka is a consultant gastroenterologist at University Hospitals Coventry and Warwickshire NHS Trust and an honorary professor of gastroenterology at Warwick Medical School. He is the UK’s representative on the European Board of Gastroenterology.
Over the past decade, Chuka has been a member of various RCP committees including Council, the Finance and Resources Board (and its predecessor the Finance and General Processes Board), and those covering the organisation of gastroenterology services and training.
He has also been an active member of the British Society of Gastroenterology (BSG), both as a Council member and as treasurer of the BSG between 2003–8. He was president of the Midlands Gastroenterological Society in 2015.
Professor Donal O’Donoghue is the registrar of the RCP, consultant renal physician at Salford Royal Hospital and professor of renal medicine at the University of Manchester.
Donal qualified in physiology and medicine from Manchester, and trained in internal medicine and nephrology in the east Midlands and north-west of England, Paris (as a Medical Research Council travelling fellow), France, and in Edinburgh, Scotland.
In Manchester, he led the reorganisation of renal services and established the first managed clinical network in England. Donal was inaugural president of the multiprofessional British Renal Society. Between 2006 and 2013 he led the implementation of the Renal National Service Framework as national director of kidney care at the Department of Health. Donal was president of the Renal Association from 2016 until 2018 and was awarded an OBE for services to kidney patients in 2018.
Donal is passionate about professionalism in medicine, innovation and quality improvement in health and care. At the RCP Donal’s responsibilities include clinical and professional affairs, and he takes a lead role in matters relating to membership, governance, regional activity, global programmes and relationships with the NHS.
In addition to clinical duties in Salford, Donal remains active in training and research. He chairs the Greater Manchester, Lancashire and South Cumbria Senate and is medical director of Health Innovation Manchester. He is chair of the patient support charity Kidney Care UK.
In July 2016 Professor David Oliver was elected clinical vice president of the Royal College of Physicians, working in the Care Quality Improvement Department.
David is currently seconded to the King’s Fund as visiting fellow, alongside his clinical job as an NHS consultant in geriatrics and general internal medicine at the Royal Berkshire NHS Foundation Trust, where he was also lead clinician and clinical director. While at the King’s Fund, he co-authored the report Making our health and care systems fit for an ageing population and worked with numerous health economies advising on integrated services for older people, and co-organised conferences, workshops and blogs regularly.
He is immediate past president of the British Geriatrics Society having also been its honorary secretary. He is also visiting professor of medicine for older people at City, University of London.
A hospital doctor since 1989, David was a consultant and clinical director at South London NHS Trust from 1998 to 2004 and was the Department of Health national clinical director for older people from 2009 to 2013. He has just finished 3 years as specialist clinical adviser for the NHS Emergency Care Improvement Partnership, visiting and working with over 30 acute hospitals and healthcare systems.
David writes a weekly freelance column, ‘Acute perspective’ in the BMJ, which was shortlisted for the 2017 PPA columnist of the year award. He has written for several other professional and general publications, and has published more than 120 research papers, reviews, book chapters and editorials.
In addition to his medical qualifications and research doctorate, David has master’s degrees in health leadership, healthcare ethics and law, and postgraduate diplomas in health service management and medical education. He was recently named in the Health Service Journal’s top 100 clinical leaders and top 50 integrated care leaders lists. He tweets as @mancunianmedic.
David is the Deputy Director of Education at the Royal College of Physicians.
His areas of expertise include faculty development, leadership and teaching in clinical and non-clinical settings. His role at the Royal College of Physicians involves the management, delivery and development of a large number of educational programmes, designed to meet the needs of healthcare practitioners both nationally and internationally.
Doctor Hermione Price is a Consultant Diabetologist at Southern Health NHS Foundation Trust and at the Royal Bournemouth Hospital.
Prior to joining Southern Health Hermione spent a year as a Department of Health Fellow working with the National Clinical Director for Diabetes, the diabetes policy team and NHS Diabetes (now part of NHS Improvement) .
Hermione chaired the Diabetes Forum (Wessex Cardiovascular Strategic Clinical Network) for many years and has recently been appointed as the joint specialty lead for diabetes at the Wessex Clinical Research Network.
Hermione was awarded her DPhil from the University of Oxford in 2010 for her thesis entitled “The impact of personalised cardiovascular disease risk factor information on physical activity in adults at increased risk of cardiovascular disease”.
Hermione is an Honorary Senior Clinical Lecturer with the University of Southampton and is currently supervising two clinical fellows undertaking PhDs and a Masters student. Her research interests are focussed around the interface between diabetes and serious mental illness and the delivery of diabetes care at scale. Hermione also has a clinical interest in the management of diabetes and obesity in people with serious mental illness. She provides an in-reach service to a medium secure hospital, joint clinics with psychiatry colleagues and co-authored the national guidelines concerning the management of diabetes in people with serious mental illness.
Hermione has published extensively in peer-reviewed journals and is frequently invited to speak at national and international meetings particularly on the subject of diabetes and mental illness.
Dr Ananthakrishnan Raghuram has been a consultant in general and respiratory medicine since 2002. He did his general medical and respiratory training on the prestigious north-western rotation and now works at Cheltenham General Hospital.
‘Raghu’ is a consultant thoracic physician in Gloucestershire and was appointed as the RCP Linacre fellow with responsibilities for supporting RCP and associate college tutors. Alongside this, he is currently the RCP regional adviser and head of school of medicine in the Severn region, and previously held the role of RCP censor.
As a chief examiner and host for MRCP PACES, Dr Raghuram sits on the MRCP Part II exam board and is on the implementation committee developing the new internal medicine curriculum for the Joint Royal Colleges of Physicians Training Board (JRCPTB).
Dr Keith Ridge is Chief Pharmaceutical Officer at NHS England where he is head of profession for the pharmacy professions and the principal advisor on pharmacy and medicines use.
His role supports NHS Improvement, the Department of Health, broader Government and Health Education England.
Keith is the Senior Responsible Officer for reducing inappropriate prescribing of antimicrobials in the UK AMR Strategy, and leads on issues such as medicines optimisation, digital medicines, clinical pharmacy in primary care, pharmacy educational reform and transforming pharmacy practice in line with the NHS Long Term Plan.
Since becoming Chief Pharmaceutical Officer at the Department of Health in 2006, Keith has led major changes to pharmacy including the establishment of a new pharmacy professional regulator, the General Pharmaceutical Council, the ongoing delivery of 2,000 clinical pharmacists as part of the General Practice Forward View, and the establishment of the national Medicines Value and Medicines Safety programmes. In late 2018, he was asked by the Secretary of State for Health and Social Care to lead a review into polypharmacy and over-prescribing.
He is a visiting professor at the Imperial College Medical School.
Matthew’s a less than full time trainee working in geriatric medicine with special interests in medical education and leadership development. Alongside his clinical work he co-chairs the RCP Trainees’ Committee, is an Honorary Lecturer at the University of Sheffield leading an MSc module on Health, Healthcare and Research in Older People and is a member of Health Education Yorkshire and the Humber’s Leadership Faculty teaching healthcare professionals basic leadership skills. He’s recently returned to training having worked for a year in Health Education England developing Core Medical Training in Yorkshire and the Humber.
Jonathan Sheffield has been Chief Executive Officer of the National Institute for Health Research, Clinical Research Network since 2010. The Clinical Research Network delivers Clinical research studies throughout the NHS in England covering primary, secondary and tertiary care.
A passionate advocate for clinical research, Jonathan’s ambition is to focus not only on traditional pharma and medical technology research but how digital tools can accelerate delivery of life-changing treatments whilst improving engagement with patients, researchers, Life Science industry and the wider NHS.
Professor Tom Solomon is chair of neurological science at the University of Liverpool’s Institute of Infection and Global Health and the Walton Centre NHS Foundation Trust, and director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections. After qualifying in medicine at Oxford University, his research training included 3 years at the Oxford University Clinical Research Unit in Vietnam, and 2 years at the University of Texas Medical Brain, Galveston, USA.
He heads the multidisciplinary Liverpool Brain Infections Group. With nearly £30 million in research funding, the group works to reduce the UK and global burden of neurological disease in adults and children caused by infections, with major programmes on Japanese encephalitis in Asia, and Zika and Chikungunya in Latin America.
Tom is a keen teacher, running the annual ‘Neurological infectious diseases’ course in Liverpool, and an enthusiastic science communicator; his popular science book Roald Dahl’s Marvellous Medicine was published in 2016. He tweets @RunningMadProf
Professor Robert Storey is professor of cardiology at the University of Sheffield, Sheffield, UK, where he has headed a thrombosis research group since 2002 and is director of the Cardiovascular Research Unit. In addition, Prof Storey is academic director and honorary consultant cardiologist for the Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals NHS Foundation Trust. He has a special interest in the management of ischaemic heart disease, including acute coronary syndromes and coronary intervention.
He served as a member of the executive committees for the DISPERSE2, PLATO and PEGASUS-TIMI 54 studies, leading the platelet function sub-studies for these trials, and of the steering committees for the TRA-CER, EPICOR and ATLANTIC studies. He is currently a member of the steering committees for the COMPLETE, RAPID CTCA, SENIOR RITA, AUGUSTUS and CLEAR SYNERGY studies. He was chair of the working group on thrombosis of the European Society of Cardiology (ESC) from 2012–2014 and has been a task force member for several ESC guidelines on non-ST-elevation acute coronary syndromes (2011 and 2015) and dyslipidaemias (2011).
Professor Cheng-Hock Toh was elected academic vice president of the Royal College of Physicians (RCP) in July 2018.
Cheng-Hock is professor of haematology at the University of Liverpool and honorary consultant haematologist at the Royal Liverpool University Hospital. He is president of the British Society for Haematology and national haematology lead of the National Institute for Health Research (NIHR) Clinical Research Network.
He has trained in Sheffield, Manchester and Newcastle as well as at Johns Hopkins University, USA, and Queen’s University, Canada. His translational research programme on understanding blood changes during sepsis and critical illness has led to patented discoveries and guidelines to improve standards in patient care.
Dr Emma Vaux is a consultant nephrologist and general physician at the Royal Berkshire NHS Foundation Trust and senior censor and vice president (education and training) at the Royal College of Physicians (RCP).
As a clinical associate, Emma leads the Academy of Medical Royal Colleges’ Quality Improvement: Training for Better Outcomes work on embedding quality improvement training into medical training, building on the RCP’s Learning to Make a Difference programme which she led for 7 years. Emma also sits on the editorial board for the Future Healthcare Journal and QI4U, and is a Generation Q fellow and Q founding member with The Health Foundation.
After completing her medical degree at the University of London, Emma was awarded a research doctorate from Oxford University. She has completed a postgraduate certificate in teaching and learning in higher and professional education at the University of London, and currently leads an active clinical research programme.
Alongside her clinical work, Emma’s other roles include specialty advisor with the Care Quality Commission, National Children and Adult Services (NCAS) case investigator, NCAS lead assessor and clinical lead at the Oxford Academic Health Science Network (AHSN) Patient Safety Collaborative acute kidney injury workstream.
Professor Bee Wee is national clinical director for end of life care at NHS England and at NHS Improvement (for 2 days and 1 day each week, respectively). In this role, she provides strategic leadership for improving palliative and end-of-life care across England. In 2015, she co-led the development and publication of the Ambitions for palliative and end of life care: A national framework for local action 2015–2020. This framework was jointly developed with 27 partners across health and care, and statutory and voluntary sectors. It was endorsed in the government’s response to the Review of choice in end of life care in 2016. She was awarded the Presidential Medal by the European Society for Person Centered Healthcare for her academic, policy and clinical contributions to person-centred healthcare in 2017. She received an honorary doctorate of science from Oxford Brookes University in 2018.
Originally from Malaysia, she trained in medicine, then general practice, in Ireland; worked in Hong Kong; then became consultant/senior lecturer in palliative medicine, and later, deputy director of the Medical School, Southampton University. She moved to Oxford in 2003 as consultant in palliative medicine at Sir Michael Sobell House, fellow of Harris Manchester College and associate director of clinical studies at Oxford University, and head of the Oxford WHO Collaborating Centre for Palliative Care. She is a past president of the Association for Palliative Medicine of Great Britain and Ireland. Her clinical and academic base remains in Oxford. She is now associate professor at Oxford University, visiting professor at University of Worcester, and honorary professor at Sichuan University, China. In her spare time, she enjoys cooking, eating and allotment gardening with her husband, Richard.
Professor Anthony Wierzbicki is consultant in metabolic medicine/chemical pathology at Guy’s & St. Thomas’ Hospitals and honorary Professor in Cardiometabolic Disease at King’s College, London. He runs a regional centre for lipid disorders and set up the regional bariatric service. He is clinical lead for Blood Sciences at Viapath at Guy’s & St Thomas’ Hospitals. He is secretary of the national network of specialist Lipid laboratories. His research interests are in the role of lipids in atherosclerosis and in peroxisomal diseases. He is a Fellow of the American Heart Association and the National Academy of Clinical Biochemistry (USA). He has 300 publications, 19 book chapters and written 1 book. He was a trustee of HEART-UK (United Kingdom Cholesterol charity) and chairman of its medical and scientific committee (2002-08).
At the National Institute for Health and Clinical Excellence (NICE) he has served on the Technology Appraisal (2006-9), Highly Specialised (orphan disease) Therapies (2013-5) and Diagnostics Appraisal committees (2014-). He was a member of the Familial Hypercholesterolaemia guideline group (CG71; 2008-2009) and chair of the Lipid Modification (CG181; 2012-4); Chronic Heart Failure (2016-18), Hypertension (2017-) and now Kidney Injury guidelines (2018-). He helped write the International guidelines on Familial Hypercholesterolaemia (2014) and the American Heart Association scientific consensus statement on Familial Hypercholesterolemia (2015).
President British Association of Sexual Health and HIV
As a Consultant leading Sexual Health & HIV services in North Wales over past 27 years , I have been passionate about improving services for women especially those who experience sexual violence , child sexual exploitation –set up Amethyst SARC along with Sexual Health and HIV Services.
As Chief of Staff (2009-15) I was responsible for leading on virtual clinic project C@rtref , Royal College of Physicians Future Hospital development site.
Council Member Bangor University and Trustee at NAT (National AIDS Trust)
Received OBE for Services to Medicine in Wales in 2005
Bryan Williams is chair of medicine at University College London and director of the National Institutes for Health Research (NIHR) University College London Hospitals Biomedical Research Centre. He is also the director of research for UCL Hospitals NHS Foundation Trust. He is a consultant physician at UCL Hospitals and a NIHR Senior Investigator and a member of the NIHR Strategy Board. He is national co-chairman of the Cardiovascular Specialty Group for the NIHR Comprehensive Research Network. He has recently been appointed onto the National Institute of Clinical Excellence (NICE) Hypertension in Adults Guideline Committee (2017). He was previously professor of medicine (1996–2012) and chairman of the division of medicine at the University of Leicester School of Medicine, UK. He graduated from the University of London in 1983 and completed his clinical and research training in London, Leicester, and at the University of Colorado Health Sciences Center in Denver, Colorado, USA.
Professor Williams’ research and clinical practice is in the field of hypertension in which he is recognised as one of the world’s leading authorities. His research in the sphere of human experimental medicine focuses on developing clinically applicable models for the human non-invasive assessment of aortic pressure and haemodynamics, in which he published the most cited and influential paper in the field that is credited with driving an exponential rise in clinical device and technology development. He has received numerous national and international awards and was the recent recipient of the Times Higher Education University award for ‘Outstanding Innovation and Technology 2011’ for his work on methods for the non-invasive measurement of aortic pressure, and the Sleight Award (2014) by the European Society of Hypertension for his ‘outstanding contribution to research, education and clinical practice in the field of hypertension’.
Professor Williams is the past president of the British Hypertension Society (2001–2003) and is chairman of the NICE Hypertension Guidelines Development Group (published in 2011), chairman of the NICE Hypertension National Quality Standards development group (April 2013) and chairman of the NICE Evidence Update for Hypertension report (March 2013). He was previously chairman of the Clinician Scientist Research Grant Awards panels for the Medical Research Council and the Department of Health, and a member of the NIHR Efficacy and Evaluation (EME) board. He is a member of national and international hypertension societies, and a fellow of the American Heart Association, the European Society of Cardiology and the Royal College of Physicians, London.